The pursuit of outperformance leads many investors to carefully choose individual stocks. Picking the right ones can be a game-changer for growing your wealth.
After finishing at $1.6 in the prior trading day, INmune Bio Inc (NASDAQ: INMB) closed at $1.56, down -2.50%. In other words, the price has decreased by -$2.50 from its previous closing price. On the day, 0.49 million shares were traded. INMB stock price reached its highest trading level at $1.605 during the session, while it also had its lowest trading level at $1.54.
Ratios:
Our goal is to gain a better understanding of INMB by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 4.17 and its Current Ratio is at 4.17. In the meantime, Its Debt-to-Equity ratio is 0.04 whereas as Long-Term Debt/Eq ratio is at 0.02.
On January 28, 2025, Rodman & Renshaw started tracking the stock assigning a Buy rating and target price of $23.Rodman & Renshaw initiated its Buy rating on January 28, 2025, with a $23 target price.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, INMB now has a Market Capitalization of 41473004 and an Enterprise Value of 14819002. For the stock, the TTM Price-to-Sale (P/S) ratio is 829.53 while its Price-to-Book (P/B) ratio in mrq is 1.63. Its current Enterprise Value per Revenue stands at 296.38.
Stock Price History:
The Beta on a monthly basis for INMB is 0.71, which has changed by -0.6754564 over the last 52 weeks, in comparison to a change of 0.17511821 over the same period for the S&P500. Over the past 52 weeks, INMB has reached a high of $11.64, while it has fallen to a 52-week low of $1.38. The 50-Day Moving Average of the stock is -10.06%, while the 200-Day Moving Average is calculated to be -60.76%.
Shares Statistics:
The stock has traded on average 412.60K shares per day over the past 3-months and 363130 shares per day over the last 10 days, according to various share statistics. A total of 26.59M shares are outstanding, with a floating share count of 22.06M. Insiders hold about 17.01% of the company’s shares, while institutions hold 17.63% stake in the company. Shares short for INMB as of 1765756800 were 3419054 with a Short Ratio of 8.29, compared to 1763078400 on 3449639. Therefore, it implies a Short% of Shares Outstanding of 3419054 and a Short% of Float of 16.830000000000002.
Earnings Estimates
The market rating for INmune Bio Inc (INMB) is a result of the insights provided by 2.0 analysts actively involved in the assessment.The consensus estimate for the next quarter is -$0.34, with high estimates of -$0.34 and low estimates of -$0.34. Analysts are recommending an EPS of between -$1.25 and -$1.5 for the fiscal current year, implying an average EPS of -$1.38. EPS for the following year is -$0.99, with 3.0 analysts recommending between -$0.72 and -$1.3.
